États-Unis · Bourse & Finance · The Motley Fool

Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline

Publié par The Motley Fool · États-Unis il y a 10 h

Wall Street is quite bullish on BioNTech. In fact, among the 20 analysts covering it, 13 rate the stock a strong buy, while the remainder rate it a hold. Their target prices imply…

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline

À lire aussi

Replit is no longer working with Anthropic, CEO says

My 2 friends and I had babies within 3 weeks of each other after 25 years of friendship. Our group chat became a lifeline.

Weak Links Start to Show in A.I. Borrowing

Alberta has the world’s fourth-largest oil reserves and sends 90% of its crude exports to the U.S. — It will vote on a first step to leaving Canada

Bulls vs. Bears: Is CoreWeave the canary in AI coalmine?

Crypto Super PAC Fairshake Pours Millions More Into Defeating Sherrod Brown

Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline

Partager

À lire aussi

Replit is no longer working with Anthropic, CEO says

My 2 friends and I had babies within 3 weeks of each other after 25 years of friendship. Our group chat became a lifeline.

Weak Links Start to Show in A.I. Borrowing

Alberta has the world’s fourth-largest oil reserves and sends 90% of its crude exports to the U.S. — It will vote on a first step to leaving Canada

Bulls vs. Bears: Is CoreWeave the canary in AI coalmine?

Crypto Super PAC Fairshake Pours Millions More Into Defeating Sherrod Brown